Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations


Endometrial cancer is now recognized to be several diseases with differing biology and responses to treatment. Improved molecular characterization has furthered the development and testing of targeted therapies in the different cohorts of endometrial cancer. Lessons are being learned from other cancers that share similar molecular typing, and hence, potentially similar tumor behavior. This commentary serves as a broad overview of the types of advances to which our patients now have access.

Original languageEnglish (US)
Article number5020
Issue number20
StatePublished - Oct 2022
Externally publishedYes


  • endometrial cancer
  • molecular subtyping
  • targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer'. Together they form a unique fingerprint.

Cite this